AstraZeneca PLC ADR outperforms market on strong trading day
The AstraZeneca +0.73% inched 0.73% higher to $64.59 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA, +1.47% rising 1.47% to 35,950.89 and the NASDAQ Composite Index COMP, -0.23% falling 0.23% to 14,226.22.
This was the ADR's second consecutive day of gains.
AstraZeneca PLC ADR closed $11.97 short of its 52-week high ($76.56), which the company achieved on April 25th.
The ADR demonstrated a mixed performance when compared to some of its competitors Thursday, as Eli Lilly & Co. LLY, -0.14% fell 0.14% to $591.04, Biogen Inc. BIIB, +0.87% rose 0.87% to $234.08, and Johnson & Johnson JNJ, +1.68% rose 1.68% to $154.66.
Trading volume (10.0 M) eclipsed its 50-day average volume of 5.7 M.
Editor's Note: This story was auto-generated by Automated Insights , an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
